Serum sphingolipid profiling as a novel biomarker for metabolic syndrome characterization
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.1092331
Abstract: Background Sphingolipids are components of cell membrane structure, but also circulate in serum and are essential mediators of many cellular functions. While ceramides have been proposed previously as a useful biomarker for cardiometabolic disease, the… read more here.
Keywords: sphingolipid profiling; biomarker; serum sphingolipid; metabolic syndrome ... See more keywords